Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers
Conversion Rate of TST and Quantiferon-TB Gold In Tube Assay in Health Care Workers
1 other identifier
observational
53
1 country
1
Brief Summary
The purpose of this study is to access conversion rate of TST (Tuberculin skin test) and Quantiferon-TB Gold In tube assay in health care workers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 16, 2011
CompletedFirst Posted
Study publicly available on registry
June 20, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedMarch 6, 2013
March 1, 2013
11 months
June 16, 2011
March 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
conversion rate of latent tuberculosis infection in hospital workers
3months
Study Arms (1)
Health care workers
health care workers who performed TST or Quantiferon-TB Gold In tube assay before
Eligibility Criteria
health care workers who performed TST or Quantiferon-TB Gold In tube assay before
You may qualify if:
- age 20-75, men and women
- participant who was enrolled in the study of latent tuberculosis in health care worker (IRB No.4-2009-0187)
- high risk or low risk health care worker who was performed TST or Quantiferon-TB Gold In tube assay before
You may not qualify if:
- age \< 20
- person who don't agree with enrollment
- illiterate
- person who is diagnosed as active tuberculosis now
- person who has history of hypersensitivity on PPD (tuberculin purified protein derivative)
- pregnant woman
- person who is treated as active tuberculosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital
Seoul, 120-752, South Korea
Related Publications (4)
Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med. 1995 Jan 12;332(2):92-8. doi: 10.1056/NEJM199501123320206. No abstract available.
PMID: 7990907BACKGROUNDJiamjarasrangsi W, Hirunsuthikul N, Kamolratanakul P. Tuberculosis among health care workers at King Chulalongkorn Memorial Hospital, 1988-2002. Int J Tuberc Lung Dis. 2005 Nov;9(11):1253-8.
PMID: 16333934BACKGROUNDSchwartzman K, Loo V, Pasztor J, Menzies D. Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1006-12. doi: 10.1164/ajrccm.154.4.8887599.
PMID: 8887599BACKGROUNDKruuner A, Danilovitsh M, Pehme L, Laisaar T, Hoffner SE, Katila ML. Tuberculosis as an occupational hazard for health care workers in Estonia. Int J Tuberc Lung Dis. 2001 Feb;5(2):170-6.
PMID: 11258511BACKGROUND
Biospecimen
whole blood for perfoming Quantiferon-TB Gold in tube assay
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2011
First Posted
June 20, 2011
Study Start
June 1, 2011
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
March 6, 2013
Record last verified: 2013-03